DK42580A - Fremgangsmaade til fremstilling af 3-(1-imidazolylylalkyl)indoler - Google Patents

Fremgangsmaade til fremstilling af 3-(1-imidazolylylalkyl)indoler

Info

Publication number: DK42580A
Authority: DK; Denmark
Prior art keywords: imidazolylylylkyl; indoles; preparing
Prior art date: 1979-03-07

Application number

DK42580A

Other languages

English (en)

Other versions

DK151884B (da

DK151884C (da

Inventor

P E Cross

R P Dickinson

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-03-07

Filing date

1980-01-31

Publication date

1980-09-08

1980-01-31 Application filed by Pfizer filed Critical Pfizer

1980-09-08 Publication of DK42580A publication Critical patent/DK42580A/da

1988-01-11 Publication of DK151884B publication Critical patent/DK151884B/da

1988-06-13 Application granted granted Critical

1988-06-13 Publication of DK151884C publication Critical patent/DK151884C/da

Links

150000002475 indoles Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DK042580A 1979-03-07 1980-01-31 Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf DK151884C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB7908123		1979-03-07
GB7908123		1979-03-07

Publications (3)

Publication Number	Publication Date
DK42580A true DK42580A (da)	1980-09-08
DK151884B DK151884B (da)	1988-01-11
DK151884C DK151884C (da)	1988-06-13

Family

ID=10503707

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK042580A DK151884C (da)	1979-03-07	1980-01-31	Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf

Country Status (36)

Country	Link
US (1)	US4273782A (da)
JP (1)	JPS55133380A (da)
KR (1)	KR850000760B1 (da)
AR (1)	AR227015A1 (da)
AT (1)	AT375366B (da)
AU (1)	AU516957B2 (da)
BE (1)	BE882113A (da)
CA (1)	CA1120479A (da)
CH (1)	CH649546A5 (da)
CS (1)	CS253702B2 (da)
DD (1)	DD149525A5 (da)
DE (1)	DE3008632A1 (da)
DK (1)	DK151884C (da)
ES (2)	ES489220A0 (da)
FI (1)	FI66860C (da)
FR (1)	FR2450832A1 (da)
GR (1)	GR67237B (da)
HK (1)	HK89884A (da)
HU (1)	HU184727B (da)
IE (1)	IE49542B1 (da)
IL (1)	IL59524A (da)
IT (1)	IT1218420B (da)
KE (1)	KE3467A (da)
LU (1)	LU82224A1 (da)
MY (1)	MY8500285A (da)
NL (1)	NL182959C (da)
NO (1)	NO152217C (da)
NZ (1)	NZ193052A (da)
PH (1)	PH15198A (da)
PL (1)	PL128296B1 (da)
PT (1)	PT70914A (da)
SE (1)	SE440778B (da)
SG (1)	SG67284G (da)
SU (1)	SU1277894A3 (da)
YU (1)	YU41911B (da)
ZA (1)	ZA801328B (da)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4414159A (en) *	1980-09-26	1983-11-08	E. I. Du Pont De Nemours & Co.	Vinyl ether monomers and polymers therefrom
US4444775A (en) *	1981-06-22	1984-04-24	Ciba-Geigy Corporation	Substituted imidazo[1,5-A]pyridines
KR840000529A (ko) *	1981-07-07	1984-02-25	콘스탄틴 루이스 클레멘트	인돌 유도체의 제조방법
ZA825413B (en) *	1981-08-26	1983-06-29	Pfizer	Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them
US4478842A (en) *	1981-11-19	1984-10-23	Ciba-Geigy Corporation	N-Substituted-2-pyridylindoles
US4460777A (en) *	1981-11-19	1984-07-17	Ciba-Geigy Corporation	N-Substituted-2-pyridylindoles
US4539410A (en) *	1982-09-30	1985-09-03	Ciba-Geigy Corporation	N-Substituted-2-(1-imidazolyl)indoles
US4436746A (en)	1982-09-30	1984-03-13	Ciba-Geigy Corporation	Thromboxane synthetase inhibitory N-substituted-2-(1-imidazolyl)indoles
AT376436B (de) *	1982-11-05	1984-11-26	Laevosan Gmbh & Co Kg	Verfahren zur herstellung neuer thiophen-2carbons[urederivate und pharmazeutisch vertraeglicher saeure- oder basenadditionssalze davon
US4511573A (en) *	1983-05-17	1985-04-16	Ciba-Geigy Corporation	3-Substituted-2-(heteroaryl) indoles
ATE90076T1 (de)	1986-03-27	1993-06-15	Merck Frosst Canada Inc	Tetrahydrocarbazole ester.
JPH0832679B2 (ja) *	1986-09-05	1996-03-29	理化学研究所	Ｎ―フタルイシド誘導体及びその製造法
GR871809B (en) *	1986-11-28	1988-03-07	Glaxo Group Ltd	Process for the preparation of tricyclic ketones
AU5279390A (en) *	1989-03-31	1990-11-05	Kyoto Pharmaceutical Industries, Ltd.	New imidazole derivatives, production thereof, and uses thereof as medicines
SI9111010B (sl) *	1990-06-07	2005-02-28	Astrazeneca Ab	3,5-disubstituirani indolni derivati kot "5-HT1-podobni" receptorski agonisti
DE4023215A1 (de) *	1990-07-21	1992-01-23	Hoechst Ag	Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung
JPH06500551A (ja) *	1990-09-13	1994-01-20	ビーチャム・グループ・パブリック・リミテッド・カンパニー	５ｈｔ受容体アンタゴニストとしてのインドールウレア
US5162337A (en) *	1990-10-05	1992-11-10	Merck & Co., Inc.	Animal growth promotion
US5120749A (en) *	1991-02-20	1992-06-09	Abbott Laboratories	Platelet activating antagonists
ES2090956T3 (es) *	1991-12-18	1996-10-16	Schering Corp	Imidazolil o imidazolilalquil sustituido con un anillo heterociclico de cuatro o cinco miembros que contiene nitrogeno.
US5538973A (en) *	1992-03-27	1996-07-23	Kyoto Pharmaceutical Industries, Ltd.	Imidazole derivative, pharmaceutical use thereof, and intermediate therefor
CA2109931A1 (en) *	1992-03-27	1993-10-14	Hiroshi Matsui	Novel imidazole derivative, pharmaceutical use thereof, and intermediate therefor
JPH0632913U (ja) *	1992-09-18	1994-04-28	三洋電機株式会社	床暖房用パネル
WO1999050268A2 (en) *	1998-03-31	1999-10-07	The Institutes For Pharmaceutical Discovery, Inc.	Substituted indolealkanoic acids
EP1539746B1 (en) *	2002-09-12	2006-11-15	F. Hoffmann-La Roche Ag	N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes
MXPA05005445A (es) *	2002-11-25	2005-08-26	Hoffmann La Roche	Derivados de indolilo.
ATE331708T1 (de) *	2002-12-10	2006-07-15	Wyeth Corp	Substituierte 3-alkyl- und 3-arylalkyl-1h-indol-1-yl-essigsäure-derivate als plasminogen aktivator inhibitor-1 (pai-1) inhibitoren
GB0324763D0 (en) *	2003-10-23	2003-11-26	Oxagen Ltd	Use of compounds in therapy
DK1756096T3 (da) *	2004-05-03	2009-10-26	Hoffmann La Roche	Indolylderivater som lever-X-receptormodulatorer
AU2005296305A1 (en) *	2004-10-12	2006-04-27	Decode Genetics Ehf	Sulfonamide peri-substituted bicyclics for occlusive artery disease
ATE517883T1 (de) *	2005-08-25	2011-08-15	Schering Corp	Imidazolderivate als funktionelle selektive agonisten des alpha2c-adrenorezeptors
US8399666B2 (en) *	2005-11-04	2013-03-19	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) *	2005-11-04	2010-03-17	Amira Pharmaceuticals Inc	5-Lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) *	2005-11-04	2011-07-12	Amira Pharmaceuticals, Inc.	5-lipdxygenase-activating protein (FLAP) inhibitors
EP2027117A2 (en) *	2006-05-16	2009-02-25	Decode Genetics EHF	Process for preparing 7-(acryloyl)-indoles
PT2046740E (pt)	2006-07-22	2012-08-28	Oxagen Ltd	Compostos com atividade antagonista do crth2
TW200920369A (en) *	2007-10-26	2009-05-16	Amira Pharmaceuticals Inc	5-lipoxygenase activating protein (flap) inhibitor
US20110015158A1 (en)	2007-12-11	2011-01-20	Viamet Pharmaceuticals, Inc.	Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
US7750027B2 (en)	2008-01-18	2010-07-06	Oxagen Limited	Compounds having CRTH2 antagonist activity
PT2250161E (pt)	2008-01-18	2014-01-21	Atopix Therapeutics Ltd	Compostos tendo atividade antagonista de crth2
JP2011509991A (ja) *	2008-01-22	2011-03-31	オキサジェンリミテッド	Ｃｒｔｈ２アンタゴニスト活性を有する化合物
WO2009093026A1 (en) *	2008-01-22	2009-07-30	Oxagen Limited	Compounds having crth2 antagonist activity
BRPI0912267A2 (pt) *	2008-05-23	2015-10-13	Amira Pharmaceuticals Inc	sal farmaceuticamente aceitável, composição farmacêutica, artigo de fabricação, métodos para tratar asma, rinite alérgica, doença, lesões gástricas e dor, métodos para prevenir broncoconstrição e rinite alérgica, uso de um sal farmaceuticamente aceitável, e, processo para a preparação de um sal farmaceuticamente aceitável.
US8546431B2 (en)	2008-10-01	2013-10-01	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
CN103929961A (zh) *	2011-06-20	2014-07-16	美国阿尔茨海默病研究所公司	化合物及其治疗应用
GB201322273D0 (en)	2013-12-17	2014-01-29	Atopix Therapeutics Ltd	Process
GB201407820D0 (en)	2014-05-02	2014-06-18	Atopix Therapeutics Ltd	Polymorphic form
GB201407807D0 (en)	2014-05-02	2014-06-18	Atopix Therapeutics Ltd	Polymorphic form
US11530186B2 (en) *	2018-03-29	2022-12-20	H. Lee Moffitt Cancer Center and Research Center Institute, Inc.	Inhibitors for the β-catenin / T-cell factor protein-protein interaction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL125443C (da) *	1963-06-06
US3370063A (en) *	1964-10-05	1968-02-20	Mcneilab Inc	Substituted dimethoxy indoles and method of making the same
US3621027A (en) *	1968-03-18	1971-11-16	Endo Lab	1-aminoalkyl-2,6-diaryl 4,5,6,7 tetrahydro-4-oxindales
US3931229A (en) *	1973-08-23	1976-01-06	Warner-Lambert Company	3-Thiomethyl-2[2-(dialkylamino)ethyl]indoles
US4059583A (en) *	1975-11-13	1977-11-22	Mcneil Laboratories, Incorporated	Substituted indoles
GR66544B (da) *	1977-08-26	1981-03-26	Wellcome Found
US4140858A (en) *	1977-12-19	1979-02-20	Warner-Lambert Company	3-(1H-imidazol-1-ylmethyl)-2-(disubstitutedaminomethyl)indoles and a method for their production
EP0003901B1 (en) *	1978-02-24	1981-08-05	Pfizer Limited	3-(imidazol-1-ylalkyl)indoles as selective inhibitors of thromboxane synthetase,pharmaceutical compositions thereof, and methods for preparing them

1980
- 1980-01-31 DK DK042580A patent/DK151884C/da active
- 1980-03-04 HU HU80498A patent/HU184727B/hu not_active IP Right Cessation
- 1980-03-04 CS CS801492A patent/CS253702B2/cs unknown
- 1980-03-05 LU LU82224A patent/LU82224A1/fr unknown
- 1980-03-05 GR GR61368A patent/GR67237B/el unknown
- 1980-03-05 NZ NZ193052A patent/NZ193052A/en unknown
- 1980-03-05 PL PL1980222470A patent/PL128296B1/pl unknown
- 1980-03-05 FI FI800672A patent/FI66860C/fi not_active IP Right Cessation
- 1980-03-05 IL IL59524A patent/IL59524A/xx unknown
- 1980-03-05 YU YU614/80A patent/YU41911B/xx unknown
- 1980-03-05 ES ES489220A patent/ES489220A0/es active Granted
- 1980-03-05 US US06/127,298 patent/US4273782A/en not_active Expired - Lifetime
- 1980-03-05 SU SU802891745A patent/SU1277894A3/ru active
- 1980-03-05 SE SE8001736A patent/SE440778B/sv not_active IP Right Cessation
- 1980-03-05 PH PH23726A patent/PH15198A/en unknown
- 1980-03-06 DD DD80219495A patent/DD149525A5/de not_active IP Right Cessation
- 1980-03-06 IT IT20399/80A patent/IT1218420B/it active
- 1980-03-06 DE DE19803008632 patent/DE3008632A1/de active Granted
- 1980-03-06 AU AU56231/80A patent/AU516957B2/en not_active Ceased
- 1980-03-06 BE BE0/199699A patent/BE882113A/fr not_active IP Right Cessation
- 1980-03-06 CA CA000347143A patent/CA1120479A/en not_active Expired
- 1980-03-06 PT PT70914A patent/PT70914A/pt not_active IP Right Cessation
- 1980-03-06 JP JP2856380A patent/JPS55133380A/ja active Granted
- 1980-03-06 AR AR280198A patent/AR227015A1/es active
- 1980-03-06 ZA ZA00801328A patent/ZA801328B/xx unknown
- 1980-03-06 FR FR8005054A patent/FR2450832A1/fr active Granted
- 1980-03-06 NL NLAANVRAGE8001351,A patent/NL182959C/xx not_active IP Right Cessation
- 1980-03-06 CH CH1781/80A patent/CH649546A5/de not_active IP Right Cessation
- 1980-03-06 IE IE453/80A patent/IE49542B1/en not_active IP Right Cessation
- 1980-03-06 NO NO800650A patent/NO152217C/no unknown
- 1980-03-06 AT AT0125780A patent/AT375366B/de not_active IP Right Cessation
- 1980-03-06 KR KR1019800000931A patent/KR850000760B1/ko not_active Expired
- 1980-11-14 ES ES496889A patent/ES496889A0/es active Granted
1984
- 1984-09-21 SG SG67284A patent/SG67284G/en unknown
- 1984-10-05 KE KE3467A patent/KE3467A/xx unknown
- 1984-11-15 HK HK898/84A patent/HK89884A/xx unknown
1985
- 1985-12-30 MY MY285/85A patent/MY8500285A/xx unknown

Also Published As

Publication number	Publication date
PH15198A (en)	1982-09-17
DK151884B (da)	1988-01-11
IE49542B1 (en)	1985-10-30
NO800650L (no)	1980-09-08
YU41911B (en)	1988-02-29
FR2450832A1 (fr)	1980-10-03
CS253702B2 (en)	1987-12-17
ES8205789A1 (es)	1982-08-01
PL128296B1 (en)	1984-01-31
DK151884C (da)	1988-06-13
IT1218420B (it)	1990-04-19
JPS55133380A (en)	1980-10-17
AT375366B (de)	1984-07-25
CH649546A5 (de)	1985-05-31
IL59524A (en)	1982-11-30
AU5623180A (en)	1980-09-11
ATA125780A (de)	1983-12-15
NZ193052A (en)	1984-07-06
FI66860B (fi)	1984-08-31
NO152217C (no)	1985-08-21
LU82224A1 (fr)	1980-06-06
SE440778B (sv)	1985-08-19
BE882113A (fr)	1980-09-08
FR2450832B1 (da)	1983-04-22
KE3467A (en)	1984-11-09
CA1120479A (en)	1982-03-23
JPS6141513B2 (da)	1986-09-16
MY8500285A (en)	1985-12-31
YU61480A (en)	1983-12-31
IE800453L (en)	1980-09-07
PL222470A1 (da)	1980-12-01
KR830001928A (ko)	1983-05-19
NL182959C (nl)	1988-06-16
ES8104278A1 (es)	1981-04-01
ZA801328B (en)	1981-03-25
PT70914A (en)	1980-04-01
GR67237B (da)	1981-06-25
DE3008632C2 (da)	1988-02-25
FI800672A7 (fi)	1980-09-08
ES496889A0 (es)	1982-08-01
FI66860C (fi)	1984-12-10
HU184727B (en)	1984-10-29
HK89884A (en)	1984-11-23
KR850000760B1 (ko)	1985-05-25
AU516957B2 (en)	1981-07-02
IL59524A0 (en)	1980-06-30
AR227015A1 (es)	1982-09-15
IT8020399A0 (it)	1980-03-06
SG67284G (en)	1985-03-15
NO152217B (no)	1985-05-13
DE3008632A1 (de)	1980-10-16
US4273782A (en)	1981-06-16
NL8001351A (nl)	1980-09-09
ES489220A0 (es)	1981-04-01
SE8001736L (sv)	1980-09-08
DD149525A5 (de)	1981-07-15
SU1277894A3 (ru)	1986-12-15

Publication	Publication Date	Title
DK42580A (da)	1980-09-08	Fremgangsmaade til fremstilling af 3-(1-imidazolylylalkyl)indoler
DK540080A (da)	1981-06-20	Fremgangsmaade til fremstilling af 2-amino-4-hydroxyquinazolinderivater
DK42480A (da)	1980-08-06	Fremgangsmaade til fremstilling af 1-aryl-2-acylamido-3-fluor-1-propanoler
DK363179A (da)	1980-03-02	Fremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater
DK457779A (da)	1980-05-01	Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater
DK364579A (da)	1980-03-01	Fremgangsmaade til fremstilling af n2-arylsulfonyl-l-arginiamider
DK488379A (da)	1980-05-19	Fremgangsmaade til fremstilling af polyetherderivater
DK294880A (da)	1981-01-10	Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK413780A (da)	1981-04-02	Fremgangsmaade til fremstilling af d-6-n-propylergoliner
DK447380A (da)	1981-04-24	Fremgangsmaade til fremstilling af d3-vitaminforbindelser
DK138879A (da)	1979-10-06	Fremgangsmaade til fremstilling af lysergolderivater
DK289580A (da)	1981-01-07	Fremgangsmaade til fremstilling af heterocycliske phenoxyaminer
DK150479C (da)	1987-10-26	Fremgangsmaade til fremstilling af 2-chlor-5-trifluormethylpyridin
DK165687C (da)	1993-06-07	Fremgangsmaade til fremstilling af 2-chlorsulfinylazetidinoner
DK62880A (da)	1980-08-16	Fremgangsmaade til fremstilling af mchlorsubstituerede aniliner
DK177680A (da)	1980-10-28	Fremgangsmaade til fremstilling af 7-n-heterocyclyl-cephalosporiner
DK308180A (da)	1981-01-19	Fremgangsmaade til fremstilling af 2,3-dihydro2,2-dimethyl-7-hydroxybenzofuran
DK157850C (da)	1990-07-30	Fremgangsmaade til fremstilling af 7-acylindolin-2-oner
DK12879A (da)	1979-07-21	R fremgangsmaade til fremstilling af ergopeptidalkaloidderivate
DK165980A (da)	1980-10-20	Fremgangsmaade til fremstilling af phosphorchloridthiolater
DK375480A (da)	1981-03-05	Fremgangsmaade til fremstilling af 1,2,4-triazol-3-thioler
DK287480A (da)	1981-01-05	Fremgangsmaade til fremstilling af 2-isopropylaminopyrimidin
DK503180A (da)	1981-05-28	Fremgangsmaade til fremstilling af benzylidenderivater
DK362379A (da)	1980-03-07	Fremgangsmaade til fremstilling af alfa-alkyl-o-oxybenzylaminderivater
DK157847C (da)	1990-09-17	Fremgangsmaade til fremstilling af pyrrolidin-2-oner